Related Experiment Video
Updated: Dec 5, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.5K
Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective
Anita K Luu1, Alicia M Viloria-Petit1
1Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
International Journal of Molecular Sciences
|October 17, 2020
Summary
Tumor cells exploit mechanotransduction for progression. This review details mechanotransduction in osteosarcoma (OSA), its pathways, and therapeutic strategies, highlighting research gaps for future treatments.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Oncology
Background:
- Mechanotransduction converts mechanical stimuli into cellular biochemical changes.
- Tumor cells hijack mechanotransduction for progression.
- Osteosarcoma (OSA) is a common primary bone cancer.
Purpose of the Study:
- To review mechanotransduction in osteosarcoma (OSA).
- To discuss OSA cell mechanical properties and signaling pathways.
- To explore current and future mechanotransduction-targeting strategies for OSA.
Main Methods:
- Literature review of mechanotransduction in OSA.
- Analysis of human and canine OSA models.
- Examination of related mesenchymal malignancies like Ewing sarcoma.
Main Results:
- OSA cells possess distinct mechanical properties.
- Specific pathways mediate OSA response to mechanical cues.
- Current strategies targeting mechanotransduction in OSA are discussed.
Conclusions:
- Understanding OSA mechanotransduction is crucial for treatment.
- Targeting mechanical vulnerabilities offers therapeutic potential.
- Further research is needed to address knowledge gaps.
Keywords:
Hippo signallingTAZYAPcomparative oncologyezrinmechanotransductionmolecular targeted therapymyocardin-related transcription factor-A/-BosteosarcomaMore Related Videos
Related Concept Videos
Targeted Cancer Therapies
8.3K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.3K
mTOR Signaling and Cancer Progression
4.4K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.4K

